PrintNEWS
The life sciences in the news[Please login to post comments]
- Why 4 Billion Cell Phones Are Forever Changing Healthcare
Podcast: March 15, 2010 Read More - To the Spender Go the Spoils
Abbott buys Facet Biotechnology for $722 million. Read More - Targeting Patients Who are Sick As A Dog
Sanofi-Aventis and Merck join forces in the animal healthcare market. Read More - Intermune rounds the final corner
Shares soars as FDA panel recommends approval of company’s drug for scarring of lung tissue. Read More - Good Health Has Its Rewards
Staying healthy associated with more frequent and better quality sex in later life. Read More - A Cure for Doctors’ Handwriting
Physicians use of e-prescribing dramatically cut medication errors. Read More - An Assortment of Deals
A lukewarm IPO and a white knight spice up the week’s deals. Read More - Roche and Biogen Suspend Experimental RA Treatment
The weekly round-up of failed trials, missed targets and other business mishaps. Read More - Consumer Group Sues Over Health Insurance Increases
Podcast: March 8, 2010 Read More - Archimedes Does Some Math
Biopharma’s funding round is the largest private European financing in 15 years. Read More
.gif)
.gif)
.gif)
- Pelosi Signals Aim to Pass Health-Care Bill Before Obama Trip
Bloomberg - Birth-Control Pills Cut Cancer, Lengthen Women’s Lives in Study
Bloomberg - Plavix gets new FDA warning
Reuters - House panel to consider healthcare bill Monday
Reuters - U.S. court rules again against vaccine-autism claims
Reuters - Democrats Struggle to Finish Health Bill
The New York Times - Health Care’s Obstacle: No Will to Cut
The New York Times - House, Senate Leaders Agree on Most of Health Bill
Bloomberg - Infection Defense May Spur Alzheimer’s
The New York Times - Disease Cause Is Pinpointed With Genome
The New York Times